Dvora Joseph-Davey

Has grant

Associate Professor

University of California, Los Angeles

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Dvora Joseph-Davey is an Associate Professor at the University of California Los Angeles, USA. Her research focuses on HIV prevention, particularly in vulnerable populations such as pregnant and breastfeeding women in South Africa. Recent publications include studies on pre-exposure prophylaxis (PrEP) uptake, point-of-care diagnostics for sexually transmitted infections, and the evaluation of community-based interventions.

Recent Grants

Grant: Close

Stepped care to optimize PrEP effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa

Open Date: 2021-09-20

Close Date: 2026-05-31

Grant: Close

Evaluation of pre-exposure prophylaxis cascade in pregnant and breastfeeding women in Cape Town, South Africa

Open Date: 2018-09-21

Close Date: 2023-03-31

Grant: Close

Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)

Open Date: 2018-09-15

Close Date: 2023-06-30

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Kenneth Mayer

Professor

Harvard T.H. Chan School of Public Health

UNITED STATES

View details

Amelia Stanton

Boston University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dvora Joseph-Davey

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (23)

Community-Based Adaptation and Evaluation of a Peer-Led Intervention to Address Alcohol Use and HIV in Pregnant and Breastfeeding Women in South Africa: Protocol for Mentor Mothers+ Randomized Control Trial (Preprint)

PrEP Uptake and Utilisation Among Adolescent Girls and Young Women in Sub-Saharan Africa: A Scoping Review

Evaluation of point‐of‐care diagnostics for sexually transmitted infection on oral PrEP initiation and persistence among young people in South Africa: a randomized controlled study

Southern African HIV Clinicians Society guideline on pre-exposure prophylaxis to prevent HIV

Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study

Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study

Key stakeholders’ perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa

The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants: a modelling study.

Changes in the Vaginal Microbiome During Pregnancy and the Postpartum Period in South African Women: a Longitudinal Study.

Urgent appeal to allow all professional nurses and midwives to prescribe pre-exposure prophylaxis (PrEP) in South Africa.

Urgent appeal to allow all professional nurses and midwives to prescribe pre-exposure prophylaxis (PrEP) in South Africa

Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa.

Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa

Point-of-Care Sexually Transmitted Infection Testing Improves HIV Preexposure Prophylaxis Initiation in Pregnant Women in Antenatal Care in Cape Town, South Africa, 2019 to 2021

Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya

Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study

Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial

Recent alcohol use is associated with increased Pre-exposure Prophylaxis (PrEP) continuation and adherence among pregnant and post-partum women in South Africa.

The importance of assessing and addressing mental health barriers to PrEP use during pregnancy and postpartum in sub-Saharan Africa: state of the science and research priorities.

Non-ART trained health-care workers needed to prescribe PrEP in South Africa.

Sexual Risk among Pregnant Women at Risk of HIV Infection in Cape Town, South Africa: What Does Alcohol Have to Do with It?

HIV testing and linkage to ART following secondary distribution of HIV self‐test kits to male partners of women living with HIV: a pilot randomized control trial in Mpumalanga, South Africa

Long-term use of ART in African women of reproductive age.

Collaborators (2)

Kenneth Mayer

Amelia Stanton

Make your next move.